Delivery Order SPE2DR25D1056-SPE2DR26FY5CB
Award Date 2/6/26
Potential Completion Date 2/9/26
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,006.44 to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 1 GM vials, with an ultimate completion date of January 30, 2026. This firm fixed-price delivery order, issued on January 29, 2026, was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Cyclophosphamide is a critical chemotherapy agent used in military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,051.90 to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 2 GM/10 ML vials (10 milliliter units) with an ultimate completion date of December 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the federal government's pharmaceutical supply chain support. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 2 GM vials, with a contract value of $5,508.82 and an ultimate completion date of November 26, 2025. This competitively awarded, non-set-aside delivery order employs firm fixed price pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the Defense Logistics Agency's medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $4,841.90 to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 2 GM vials, with an ultimate completion date of November 18, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $3,735.80 contract is for the delivery of Cyclophosphamide 500 mg vials, a critical pharmaceutical product. The award has an ultimate completion date of August 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the government to...
- The Defense Logistics Agency awarded a delivery order valued at $44,261.94 to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 2 GM vials. This contract, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, operates under a firm fixed-price arrangement with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $26,197.80 on July 22, 2025, for the supply of Cyclophosphamide 2 GM vials, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,293.66 to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 2 GM vials. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on October 17, 2025, with an ultimate completion date of October 20, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,643.17 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Cyclophosphamide 25 mg, with an ultimate completion date of October 31, 2025. This non-set-aside contract represents a firm fixed price delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,424.85 to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 1 GM vials, with performance at the contractor's Conshohocken, Pennsylvania facility. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 27, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as a critical vendor for federal...